ALGN Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31

cash flows from operating activities:
net income	56,753,000	124,608,000	93,230,000	103,807,000	115,963,000	96,564,000	105,028,000	124,014,000	121,427,000	111,814,000	87,798,000	41,775,000	72,700,000	112,800,000	134,298,000	190,961,000	180,969,000	199,714,000	200,376,000	158,988,000	139,371,000	-40,602,000	1,518,131,000	121,262,000	102,524,000	147,142,000	71,848,000	97,392,000	100,872,000	106,105,000	95,866,000	10,264,000	82,555,000	69,179,000	69,420,000	47,621,000	51,367,000	50,148,000	40,546,000	48,877,000	27,616,000	31,350,000	36,177,000	39,541,000	38,247,000	35,600,000	32,444,000	42,421,000	34,537,000	29,320,000	-41,983,000																																	452,000	-2,144,000	-9,648,000	-8,782,000
adjustments to reconcile net income to net cash from operating activities:
deferred taxes	-8,650,000	-34,442,000	33,683,000	8,291,000	7,959,000	-8,541,000	18,047,000	4,107,000	13,939,000	-18,271,000	-18,417,000	-46,260,000	-7,982,000	-2,717,000	17,464,000	-32,649,000	8,143,000	10,982,000	28,979,000	10,882,000	1,792,000	-17,097,000	-1,487,154,000	-1,163,000	-4,136,000	-1,980,000	7,586,000	-17,727,000	-1,620,000	-402,000	4,069,000	23,053,000	-11,626,000	-1,644,000	7,789,000	1,075,000	-8,868,000	-2,495,000	-6,113,000	-15,441,000	3,720,000	6,000	291,000	4,611,000	3,374,000	4,727,000	12,769,000	6,703,000	8,229,000	5,341,000	931,000	4,618,000	3,937,000	4,502,000	4,726,000	-7,664,000	5,601,000	3,922,000	3,983,000					-3,352,000	177,000	0	563,000
depreciation and amortization	55,717,000	40,576,000	39,148,000	38,129,000	37,793,000	36,166,000	32,946,000	33,732,000	37,030,000	35,819,000	35,820,000	33,697,000	32,189,000	30,281,000	29,626,000	29,588,000	27,614,000	25,892,000	25,635,000	24,769,000	24,486,000	23,545,000	20,738,000	21,796,000	11,025,000	23,491,000	22,678,000	16,542,000	14,119,000	12,632,000	11,434,000	11,024,000	9,972,000	8,876,000	7,867,000	7,216,000	6,901,000	5,093,000	4,792,000	4,863,000	4,503,000	4,330,000	4,308,000	4,387,000	4,339,000	4,354,000	4,776,000	1,240,000	5,560,000	3,232,000	3,855,000	4,226,000	3,309,000	3,152,000	2,753,000	3,013,000	2,990,000	3,130,000	2,979,000	2,692,000	2,739,000	3,017,000	2,938,000	2,622,000	2,603,000	2,536,000	2,443,000	2,562,000	2,450,000	2,353,000	2,627,000	2,659,000	2,552,000	2,502,000	2,176,000	2,427,000	2,174,000	2,556,000	2,176,000	2,969,000	2,277,000	2,167,000	2,184,000	2,192,000	2,294,000	2,336,000	2,297,000
stock-based compensation	48,377,000	48,208,000	44,997,000	38,848,000	49,039,000	47,028,000	38,788,000	38,829,000	39,602,000	37,860,000	37,735,000	34,688,000	32,918,000	34,140,000	31,621,000	29,838,000	28,402,000	28,855,000	27,241,000	25,264,000	25,229,000	25,007,000	22,927,000	20,497,000	24,176,000	22,467,000	21,044,000	18,845,000	19,198,000	16,890,000	15,830,000	14,830,000	14,967,000	14,245,000	14,812,000	14,214,000	13,711,000	13,699,000	12,524,000	13,808,000	14,661,000	12,826,000	11,648,000	10,475,000	9,910,000	10,306,000	9,132,000	5,173,000	7,590,000	7,265,000	6,410,000	5,979,000	5,362,000	5,279,000	4,863,000	4,959,000	4,954,000	4,973,000	4,279,000	3,934,000	4,414,000	4,251,000	3,473,000	3,077,000	3,987,000	4,309,000	3,715,000
non-cash operating lease cost	10,047,000	10,000,000	9,457,000	9,835,000	9,563,000	9,428,000	9,612,000	9,073,000	8,503,000	7,776,000	7,755,000	7,764,000	7,681,000	7,549,000	7,526,000	7,443,000	6,951,000	6,502,000	5,911,000	5,648,000	5,671,000	5,602,000	5,546,000	4,875,000
impairment loss on assets held for sale
impairment of equity investment
other non-cash operating activities	21,756,000	4,643,000	2,950,000	5,325,000	4,554,000	4,736,000	-2,359,000	4,298,000	6,575,000	10,274,000	11,586,000	15,072,000	10,044,000	7,560,000	8,612,000	7,457,000	1,747,000	7,005,000	5,340,000	5,381,000	-1,140,000	-1,024,000	12,566,000	12,434,000	4,638,000	7,687,000	5,101,000	5,889,000	6,820,000	4,069,000	474,000	4,415,000	3,595,000	3,758,000	2,079,000	2,506,000	2,484,000	3,287,000	3,754,000	4,547,000	3,090,000	3,548,000	2,614,000	2,738,000	2,273,000	3,118,000	1,977,000
changes in assets and liabilities, net of effects of acquisitions:
accounts receivable	3,697,000	-56,104,000	-65,302,000	-18,248,000	11,693,000	-77,343,000	-69,589,000	-24,317,000	-6,617,000	-40,946,000	-32,734,000	-10,735,000	85,746,000	2,081,000	-55,543,000	-45,985,000	-51,259,000	-97,399,000	-67,423,000	-37,889,000	-166,533,000	50,884,000	13,761,000	-25,448,000	-6,511,000	-46,312,000	-42,743,000	-19,381,000	-45,577,000	-8,240,000	-36,026,000	-6,553,000	-32,399,000	-27,513,000	-24,525,000	-1,322,000	-54,689,000	-17,594,000	-20,839,000	-13,652,000	-4,219,000	-10,671,000	-12,233,000	-2,299,000	-3,523,000	-7,468,000	-13,939,000	-6,045,000	1,631,000	1,673,000	-9,240,000	6,322,000	-3,647,000	-9,415,000	-2,398,000	-5,607,000	-5,297,000	-3,472,000	-7,317,000	-2,222,000	164,000	-5,269,000	-4,857,000																	-1,421,000	-2,026,000	-2,561,000	-2,077,000	-156,000	-2,511,000	-1,438,000	-308,000
inventories	-5,989,000	1,648,000	7,396,000	-7,251,000	908,000	15,823,000	15,573,000	-1,470,000	12,575,000	-4,944,000	24,008,000	-21,573,000	-17,464,000	-41,605,000	-49,455,000	-29,201,000	-34,179,000	-33,488,000	-15,582,000	-17,336,000	9,624,000	-10,902,000	-10,496,000	-17,494,000	-14,094,000	-13,401,000	-13,280,000	-6,917,000	-1,606,000	-11,584,000	-4,002,000	5,228,000	-2,093,000	-693,000	-7,923,000	-790,000	-3,349,000	-369,000	-3,155,000	-530,000	-2,523,000	-1,844,000	1,334,000	34,000	-2,888,000	2,725,000	-1,870,000	691,000	1,048,000	-261,000	-320,000	17,000	-514,000	-1,191,000	-4,030,000	-1,083,000	-2,015,000	-648,000	-312,000	-165,000	119,000	-143,000	-319,000	-159,000											68,000					-492,000	148,000	-87,000	123,000	399,000	83,000	101,000	-229,000
prepaid expenses and other assets	18,648,000	-731,000	-21,970,000	93,810,000	54,621,000	-1,744,000	-79,160,000	-52,786,000	18,572,000	10,051,000	-26,850,000	-33,074,000	-18,221,000	34,446,000	-48,665,000	-49,890,000	-4,604,000	-35,274,000	-34,858,000	7,121,000	2,807,000	6,186,000	-37,244,000	-16,703,000	34,123,000	-13,916,000	-35,033,000	38,653,000	-38,409,000	6,507,000	-15,873,000	-2,821,000	-6,236,000	915,000	-527,000	-4,321,000	-44,000	-4,407,000	-618,000	-1,197,000	2,257,000	5,741,000	-10,527,000	-575,000	457,000	-1,016,000	-1,790,000	-648,000	490,000	352,000	-586,000	-2,233,000	350,000	-440,000	-1,530,000	-3,203,000	1,558,000	-1,243,000	207,000	1,874,000
accounts payable	14,245,000	-16,091,000	8,575,000	12,440,000	-6,885,000	-10,498,000	4,100,000	15,427,000	-12,779,000	-16,344,000	5,993,000	-9,423,000	-3,156,000	-30,969,000	7,025,000	6,252,000	19,231,000	9,200,000	-14,936,000	30,369,000	9,919,000	23,952,000	-12,034,000	20,756,000	-504,000	377,000	1,470,000	20,003,000	-5,701,000	5,144,000	5,599,000	3,955,000	-190,000	-1,112,000	5,522,000	739,000	619,000	-5,200,000	447,000	3,167,000	-494,000	3,031,000	1,871,000	-901,000	3,797,000	-274,000	265,000	132,000	-368,000	-1,561,000	1,611,000	3,882,000	-1,934,000	1,687,000	-3,641,000	3,787,000	3,913,000	469,000	-634,000	2,599,000	22,000	262,000	-271,000	-1,430,000	-424,000	502,000	738,000		-870,000	951,000	-143,000	-1,040,000	1,615,000	-2,284,000	2,913,000	1,933,000	435,000		-566,000	-442,000	700,000	751,000	-788,000	-89,000	-117,000	394,000	-434,000
accrued and other long-term liabilities	-32,227,000	32,374,000	-67,877,000	42,087,000	2,839,000	79,252,000	-34,473,000	-109,697,000	15,740,000	102,864,000	37,420,000	91,436,000	-482,000	-86,496,000	-126,400,000	51,384,000	41,509,000	66,125,000	-475,000	70,511,000	78,229,000	-37,469,000	-69,103,000	29,151,000	29,768,000	6,504,000	-5,183,000	61,686,000	28,006,000	-17,976,000	-35,466,000	5,240,000	34,348,000	24,349,000	-39,702,000	-1,340,000	34,523,000	18,990,000	-14,544,000	12,750,000	-1,547,000	9,337,000	-1,078,000	10,290,000	11,059,000	16,629,000	-15,286,000	10,333,000	-3,969,000	11,239,000	-7,941,000	3,612,000	3,258,000	5,264,000	-9,191,000	31,601,000	3,734,000	7,085,000	-5,315,000	13,445,000	6,990,000	7,197,000	-7,927,000														234,000
long-term income tax payable	7,038,000	3,776,000	3,316,000	-15,093,000	7,775,000	-17,531,000	4,570,000	207,000	3,134,000	-13,232,000	2,119,000	-2,692,000	10,676,000	-7,062,000	5,405,000	-7,814,000	12,728,000	3,615,000	3,920,000	-2,921,000	-6,588,000	353,000	6,354,000	1,186,000	3,817,000	4,800,000	4,808,000	-18,113,000	-20,045,000	-3,649,000	5,259,000
deferred revenues	-23,919,000	-29,815,000	-34,927,000	-19,902,000	-32,275,000	-13,513,000	-14,419,000	3,820,000	26,176,000	29,056,000	27,662,000	44,032,000	61,833,000	67,037,000	68,984,000	114,210,000	117,022,000	125,401,000	106,007,000	99,548,000	87,693,000	18,000,000	22,892,000	51,003,000	42,898,000	52,680,000	42,494,000	42,340,000	39,076,000	26,592,000	28,391,000	26,464,000	23,618,000	17,892,000	11,688,000	14,174,000	16,695,000	15,039,000	14,748,000	13,672,000	15,449,000	6,714,000	6,019,000	5,810,000	3,252,000	3,622,000	3,083,000	6,486,000	6,316,000	3,575,000	-1,476,000	-285,000	5,670,000	5,195,000	1,809,000	5,498,000	5,061,000	2,776,000	2,999,000	3,846,000	2,725,000	-9,499,000	5,108,000	4,476,000	4,631,000	3,316,000	3,104,000	1,401,000	899,000	816,000	857,000	890,000	292,000
net cash from operating activities	188,720,000	128,650,000	52,676,000	286,078,000	263,662,000	159,827,000	28,664,000	46,898,000	287,206,000	251,777,000	199,895,000	144,707,000	266,482,000	127,045,000	30,498,000	272,849,000	355,004,000	317,504,000	227,187,000	381,418,000	211,072,000	59,900,000	9,784,000	218,177,000	234,532,000	177,354,000	117,207,000	241,295,000	96,265,000	139,789,000	77,332,000	162,326,000	118,125,000	110,467,000	47,621,000	80,980,000	59,827,000	76,167,000	30,680,000	79,355,000	60,057,000	62,940,000	35,645,000	71,605,000	67,571,000	69,730,000	17,993,000	67,112,000	55,138,000	53,308,000	10,418,000	50,758,000	40,265,000	27,331,000	15,424,000	41,990,000	41,535,000	29,696,000	17,248,000	32,525,000	35,763,000	42,596,000	18,645,000	34,259,000	10,793,000	18,510,000	10,603,000	17,359,000	10,470,000	3,162,000	22,076,000	12,970,000	737,000					-923,000	8,984,000	7,073,000	8,510,000	9,235,000	-256,000	7,229,000	4,333,000	3,807,000	-3,247,000
capex	-19,761,000	-21,479,000	-25,289,000	-22,961,000	-29,800,000	-53,450,000	-9,369,000	-33,414,000	-21,638,000	-58,545,000	-64,119,000	-53,204,000	-75,348,000	-76,020,000	-87,328,000	-109,096,000	-124,334,000	-124,237,000	-43,431,000	-53,159,000	-21,255,000	-34,417,000	-46,085,000	-42,550,000	-26,559,000	-45,337,000	-35,261,000	-54,279,000	-53,738,000	-57,717,000	-57,578,000	-69,545,000	-48,105,000	-18,476,000	-59,569,000	-14,208,000	-17,343,000	-18,818,000	-20,207,000	-16,788,000	-10,491,000	-10,560,000	-15,612,000	-7,135,000	-6,997,000	-4,964,000	-4,996,000	-4,240,000	-5,783,000	-3,781,000	-5,608,000	-6,848,000	-5,707,000	-13,219,000	-12,559,000	-9,375,000	0	-5,697,000	-2,825,000	-6,099,000	-3,083,000	-4,319,000	-4,530,000	0	0	0	0	0	0	0	0	0	0					0	0	-1,662,000	-2,347,000	-3,397,000	-1,655,000	-3,089,000	-985,000	-2,881,000	-630,000
free cash flows	168,959,000	107,171,000	27,387,000	263,117,000	233,862,000	106,377,000	19,295,000	13,484,000	265,568,000	193,232,000	135,776,000	91,503,000	191,134,000	51,025,000	-56,830,000	163,753,000	230,670,000	193,267,000	183,756,000	328,259,000	189,817,000	25,483,000	-36,301,000	175,627,000	207,973,000	132,017,000	81,946,000	187,016,000	42,527,000	82,072,000	19,754,000	92,781,000	70,020,000	91,991,000	-11,948,000	66,772,000	42,484,000	57,349,000	10,473,000	62,567,000	49,566,000	52,380,000	20,033,000	64,470,000	60,574,000	64,766,000	12,997,000	62,872,000	49,355,000	49,527,000	4,810,000	43,910,000	34,558,000	14,112,000	2,865,000	32,615,000	41,535,000	23,999,000	14,423,000	26,426,000	32,680,000	38,277,000	14,115,000	34,259,000	10,793,000	18,510,000	10,603,000	17,359,000	10,470,000	3,162,000	22,076,000	12,970,000	737,000					-923,000	8,984,000	5,411,000	6,163,000	5,838,000	-1,911,000	4,140,000	3,348,000	926,000	-3,877,000
cash flows from investing activities:
acquisitions, net of cash acquired				0	0	0	-77,075,000					0																					0	0	-8,953,000
purchase of property, plant and equipment	-19,761,000	-21,479,000	-25,289,000	-22,961,000	-29,800,000	-53,450,000	-9,369,000	-33,414,000	-21,638,000	-58,545,000	-64,119,000	-53,204,000	-75,348,000	-76,020,000	-87,328,000	-109,096,000	-124,334,000	-124,237,000	-43,431,000	-53,159,000	-21,255,000	-34,417,000	-46,085,000	-42,550,000	-26,559,000	-45,337,000	-35,261,000	-54,279,000	-53,738,000	-57,717,000	-57,578,000	-69,545,000	-48,105,000	-18,476,000	-59,569,000	-14,208,000	-17,343,000	-18,818,000	-20,207,000	-16,788,000	-10,491,000	-10,560,000	-15,612,000	-7,135,000	-6,997,000	-4,964,000	-4,996,000	-4,240,000	-5,783,000	-3,781,000	-5,608,000	-6,848,000	-5,707,000	-13,219,000	-12,559,000	-9,375,000
proceeds from maturities of marketable securities				0	10,100,000	9,525,000	6,035,000	19,416,000	18,153,000	6,731,000	10,870,000	1,329,000	766,000	15,595,000	6,095,000					0	0	0	42,641,000	78,925,000	104,808,000	26,715,000	80,306,000	115,235,000	52,395,000	80,650,000	126,825,000	88,753,000	87,393,000	86,091,000	87,003,000	59,375,000	117,805,000	82,169,000	128,524,000	65,713,000	89,727,000	61,777,000	86,908,000	52,709,000	32,096,000	38,868,000	53,137,000	58,688,000	14,112,000
proceeds from sales of marketable securities				0	10,675,000	6,687,000	831,000	1,061,000	1,125,000	1,263,000	2,785,000	3,669,000	1,412,000	83,707,000	8,528,000					0	0	0	278,817,000	0	180,221,000	5,729,000	8,727,000	0	0	0	9,560,000	7,245,000	-61,000	20,668,000	11,684,000	6,817,000	185,078,000	23,931,000	293,000	17,493,000	0	7,013,000	5,505,000	10,714,000	39,593,000	22,119,000	10,564,000	24,798,000	1,900,000
purchase of equity investments	0			-30,955,000	0			0	-1,999,000
other investing activities				0	106,000	135,000	-6,000	150,000	54,000	68,000	6,000	-68,000	46,000	263,000	-2,452,000	-1,299,000	537,000			-604,000	0	0	1,760,000	-642,000	440,000	-12,135,000	-2,367,000	161,000	-64,000	206,000	462,000	170,000	173,000	-2,090,000	2,314,000	-180,000	-2,000,000			0	0	0	46,000	-1,000	-49,000	0	-133,000	-64,000
net cash from investing activities	-19,761,000	-31,479,000	-25,289,000	-53,916,000	-8,919,000	-112,493,000	-79,584,000	-13,324,000	-4,305,000	-125,485,000	-52,829,000	-55,810,000	-85,428,000	18,120,000	-90,198,000	-307,711,000	-131,799,000	-128,486,000	4,566,000	-44,666,000	-14,514,000	-448,537,000	276,211,000	-60,111,000	30,687,000	-246,602,000	-74,418,000	30,948,000	-78,024,000	-55,266,000	109,269,000	-19,693,000	-120,066,000	36,744,000	-145,298,000	-70,011,000	194,362,000	-16,187,000	-35,316,000	-73,736,000	-32,303,000	-23,661,000	-36,661,000	-30,254,000	-53,790,000	-18,236,000	-99,347,000	-10,745,000	-56,217,000	-140,327,000	-3,445,000	-12,652,000	-8,738,000	-18,915,000	-37,995,000	-12,309,000	-11,091,000	-180,980,000	-7,226,000	-7,364,000	-10,515,000	1,747,000	212,000	-4,477,000						15,235,000										-1,137,000	-3,149,000	-2,303,000	605,000	-386,000	652,000	-6,488,000	1,888,000
cash flows from financing activities:
proceeds from issuance of common stock	7,840,000	0	13,909,000	0	10,942,000	0	14,339,000	0	12,339,000	0	14,256,000	0	11,322,000	0	14,827,000	0	12,490,000	0	13,133,000	0	9,652,000	0	10,662,000	0	8,293,000	5,000	9,609,000	28,000	8,022,000	565,000	8,020,000	611,000	6,329,000	233,000	7,288,000	901,000	5,875,000	1,618,000	5,384,000	766,000	4,523,000	1,484,000	4,552,000	655,000	4,751,000	676,000	11,946,000	5,905,000	7,163,000	7,860,000	13,268,000	2,133,000	16,505,000	13,509,000	10,180,000	5,619,000	3,334,000	11,480,000	5,068,000	915,000	3,694,000	1,197,000	6,016,000	1,721,000	2,191,000	933,000	3,252,000	2,701,000	1,274,000	6,247,000	9,337,000	12,452,000	6,032,000	8,240,000	1,741,000	895,000	5,299,000	515,000	1,929,000	1,020,000	2,240,000	1,848,000	3,007,000	1,081,000	1,079,000	495,000	225,000
common stock repurchases, net of excise tax	-71,557,000	-96,046,000	-201,088,000
payroll taxes paid upon the vesting of equity awards	-402,000	-253,000	-19,577,000	-153,000	-370,000	-1,547,000	-26,055,000	-281,000	-506,000	-931,000	-20,857,000	-188,000	-424,000	-654,000	-51,533,000	-1,573,000	-2,455,000	-38,321,000	-66,568,000	-2,448,000	-1,636,000	-1,643,000	-45,395,000
net cash from financing activities	-64,119,000	-96,299,000	-206,756,000	-203,019,000	10,572,000	-151,559,000	-11,716,000	-350,281,000	11,833,000	-931,000	-258,961,000	-200,188,000	10,898,000	-200,654,000	-111,742,000	-101,573,000	-65,003,000	-238,321,000	-53,435,000	-2,448,000	8,016,000	-1,643,000	-34,733,000	-102,377,000	-194,782,000	-95,619,000	-92,762,000	-54,283,000	-144,406,000	-30,923,000	-139,822,000	-56,464,000	5,204,000	-51,239,000	-33,001,000	-37,905,000	-2,111,000	-46,402,000	-9,106,000	-11,831,000	-14,028,000	-67,830,000	-7,097,000	-19,502,000	-1,051,000	-66,928,000	21,061,000	10,731,000	12,994,000	-77,319,000	15,423,000	-36,614,000	10,536,000	30,035,000	6,248,000	8,840,000	3,273,000	11,379,000	3,749,000	4,689,000	3,654,000	1,103,000	5,261,000	861,000	2,126,000	841,000	3,009,000			6,122,000	9,155,000	4,791,000	2,337,000	4,740,000	16,741,000	895,000	5,299,000	98,000	1,481,000	508,000	1,755,000	1,351,000	2,528,000	846,000	550,000	399,000	-196,000
effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	-1,374,000	27,396,000	8,480,000	-27,161,000	15,204,000	-192,000	-9,004,000	15,876,000	-7,682,000	-5,744,000	2,221,000	8,908,000	-25,400,000	6,804,000	-1,826,000	-1,876,000	-6,730,000	3,976,000	-7,487,000	11,048,000	6,604,000	3,835,000	-11,007,000	4,380,000	-3,565,000	378,000	1,089,000	-1,843,000	-967,000
net increase in cash, cash equivalents, and restricted cash				1,982,000	280,519,000			-300,831,000	287,052,000			-102,383,000	166,552,000	-48,685,000	-173,268,000	-138,311,000	151,472,000	-45,327,000	170,831,000	345,352,000			240,255,000			-164,489,000	-48,884,000			49,962,000	48,494,000
cash, cash equivalents and restricted cash at beginning of the period	0	0	1,044,963,000
cash, cash equivalents and restricted cash at end of the period	103,466,000	28,268,000	874,074,000
net decrease in cash, cash equivalents, and restricted cash		28,268,000	-170,889,000				-71,640,000				-109,674,000
impairments and fair value adjustments for equity investments
purchase of marketable securities								-537,000	0	-2,000	-2,371,000	-7,536,000	0	-5,425,000	-15,041,000					0	0	0	-5,341,000	-104,479,000	-234,810,000	-228,172,000	-125,823,000	-30,169,000	-71,617,000			-33,316,000	-144,702,000	-42,449,000	-169,777,000	-121,815,000	-42,433,000	-97,438,000	-143,926,000	-140,154,000	-111,539,000	-81,891,000	-113,508,000	-86,541,000	-118,433,000	-74,259,000	-157,919,000	-89,927,000	-63,184,000	-147,524,000	-3,282,000	-13,649,000	-10,005,000	-15,667,000	-28,190,000
common stock repurchases				-202,866,000	0			-300,000,000	0	0	-292,360,000	-160,000,000	0	-200,000,000	-75,036,000	-100,000,000	-115,038,000							-100,495,000	-200,000,000	-49,504,000	-50,000,000	-50,000,000	-150,002,000	0	-100,000,000	-50,000,000	-15,000,000	-35,000,000	-3,793,000	-38,044,000	-23,174,000				-39,822,000	-49,000,000	-1,781,000		-28,417,000
activity for equity forward contracts related to accelerated stock repurchase agreements
cash, cash equivalents, and restricted cash at beginning of year
cash, cash equivalents, and restricted cash at end of year
cash, cash equivalents, and restricted cash at beginning of the period					0	0	938,519,000		0	0	942,355,000		0	0	1,100,139,000		0	0	961,474,000		0	0	551,134,000		0	0	637,566,000		0	0	450,125,000
cash, cash equivalents, and restricted cash at end of the period					280,519,000	-104,417,000	866,879,000		287,052,000	119,617,000	832,681,000		166,552,000	-48,685,000	926,871,000		151,472,000	-45,327,000	1,132,305,000		211,178,000	-386,445,000	791,389,000		66,872,000	-164,489,000	588,682,000		-127,132,000	49,962,000	498,619,000
impairments on equity investments																				2,100,000	0	887,000	2,900,000
arbitration award gain																0	0	0	-43,403,000
repayment on unsecured promissory note																0	0	0	4,594,000	9,097,000	6,741,000	6,668,000	4,419,000
proceeds from arbitration award																0	0	0	43,403,000
payments for equity forward contracts related to accelerated share repurchase agreements									0	0	40,000,000
payment for equity forward contract related to accelerated stock repurchase agreement
changes in assets and liabilities:
allowance for doubtful accounts provisions																1,255,000	730,000	374,000	455,000	-1,017,000
impairments on long-lived assets																								0	0	0	28,498,000
equity in losses of investee																								0	0	3,584,000	3,944,000	2,083,000	1,132,000	3,701,000	1,777,000	-1,731,000	1,614,000	2,215,000	1,121,000
gain on lease terminations																								0
gain from sale of equity method investment																								0	0
changes in assets and liabilities, net of effects of acquisition:
acquisition, net of cash acquired																0				0	0																											0	0							-668,000	29,000
purchase of finance lease																								0	0
payments for equity forward contracts related to accelerated stock repurchase agreements
impairment on equity investment																									0	0	3,975,000
purchase of investment in privately held company
loan repayment from equity investee																												0	0	0	30,000,000	0
allowance for doubtful accounts																																																																																							-4,000
other financing activities																											-2,190,000
purchases of investments in privately held companies																												0
loan advances to equity investee																																-13,000,000
purchase of investments in privately held companies
note repayment from privately held company																									6,587,000
employees’ taxes paid upon the vesting of restricted stock units																									-3,075,000	-2,537,000	-50,181,000	-4,311,000	-2,426,000	-31,488,000	-47,842,000	-7,075,000	-1,125,000	-1,472,000	-36,496,000	-3,592,000	-3,058,000	-635,000	-22,572,000	-3,142,000	-2,185,000	-742,000	-14,647,000	-1,847,000	-1,111,000	-197,000	-4,453,000	-432,000	-697,000	-93,000	-3,141,000	-387,000	-92,000	-219,000	-1,408,000	-416,000	-61,000	-101,000	-1,319,000	-191,000	-40,000	-94,000	-755,000
net tax benefits from stock-based awards																																				2,831,000	3,246,000	2,591,000	7,220,000
excess tax benefit from share-based payment arrangements																																				-2,830,000	-3,246,000	-2,615,000	-8,082,000	-1,733,000	-2,456,000	-1,428,000	-4,779,000	-2,506,000	-2,726,000	-2,593,000	-13,568,000			-7,592,000	-7,739,000	953,000	-1,395,000															102,000	41,000	45,000
supplemental cash flow information:
accounts payable or accrued liabilities related to property, plant and equipment																													3,427,000	2,115,000	18,739,000		1,701,000	12,629,000	7,662,000
conversion of convertible notes receivable into equity securities																													0
equity forward contract related to accelerated share repurchase
effect of foreign exchange rate changes on cash and cash equivalents, and restricted cash																															1,715,000
purchase of equity method investments																																0				0
effect of foreign exchange rate changes on cash and cash equivalents																																729,000	1,168,000	1,183,000	2,430,000	-3,737,000	164,000	-290,000	446,000	-114,000	-1,439,000	326,000	-1,780,000	-2,654,000	475,000	139,000	106,000	16,000	-573,000	90,000	-37,000	-13,000	45,000	-13,000	9,000	-75,000	-95,000	-96,000	173,000	-110,000	221,000	-52,000	-198,000	-117,000	50,000				-19,000	21,000
net increase in cash and cash equivalents																																86,898,000				-30,673,000											-60,187,000	67,114,000	11,342,000	-164,248,000	22,359,000	1,479,000	42,108,000	38,438,000	-16,314,000	38,446,000	33,622,000	-140,001,000	13,944,000	29,740,000	29,123,000	45,394,000	23,920,000	30,526,000	13,779,000	25,131,000	9,951,000			24,540,000	22,375,000	9,385,000	1,096,000					-3,135,000	4,340,000	6,444,000	7,116,000	8,283,000	2,877,000	7,689,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
cash and cash equivalents, beginning of the period																																	0	0	389,275,000		0	0	167,714,000		0	0	199,871,000		0	0	242,953,000		0	0	306,386,000		0	0	240,675,000												87,100,000
cash and cash equivalents, end of the period																																	4,431,000	97,155,000	261,027,000		252,242,000	13,288,000	154,418,000		12,287,000	-28,225,000	189,978,000		13,205,000	-15,295,000	182,766,000		11,342,000	-164,248,000	328,745,000		42,108,000	38,438,000	224,361,000												97,051,000
loan advance to equity investee
net decrease in cash and cash equivalents																																		97,155,000	-128,248,000			13,288,000	-13,296,000	-6,326,000	12,287,000	-28,225,000	-9,893,000		13,205,000																																									-2,282,000	-1,555,000
loan advance to privately held companies																																			-8,000,000
equity in losses of investee, net of tax
tax (shortfalls) benefits from stock-based awards
impairment of goodwill																																																0	0	0	40,693,000	11,926,000
impairment of long-lived assets																																																0	0	0	26,320,000
changes in assets and liabilities, excluding the effects of business combinations:
common stock repurchase																																																-2,000	3,000	-92,670,000	-2,438,000	-37,407,000	-7,272,000	0	-2,524,000
amortization of intangibles																																																		613,000	1,089,000	1,041,000	1,084,000	1,100,000	1,146,000	1,357,000	1,833,000	1,475,000	700,000	700,000	700,000	700,000	700,000	700,000	700,000	700,000	700,000	709,000	709,000	709,000	709,000	946,000	845,000	706,000	95,000	96,000	95,000	122,000	86,000
other non-cash expenses
excess tax benefit from share-based compensation arrangements
benefit from doubtful accounts, credit reserves and returns
other non-cash income
other payments for financing activities																																																	7,000
benefit from (recovery of) doubtful accounts and returns
release of restricted cash																																																		0	1,053,000
other payments for investing activities
recovery of doubtful accounts and returns																																																			-1,196,000				-119,000
other																																																			-10,000	1,141,000
maturities of marketable securities																																																			4,366,000	7,835,000	7,361,000	7,251,000	2,751,000	1,475,000	1,983,000	3,092,000	3,767,000	3,116,000	6,494,000	5,992,000	4,988,000	7,983,000	14,883,000	13,734,000	12,293,000	30,154,000	5,450,000	30,859,000	8,375,000	4,816,000	5,364,000	5,046,000				1,976,000	0	519,000	0	80,000	2,212,000	2,000,000	3,400,000	0	2,669,000
other assets																																																			26,000	1,000	-1,000				-596,000	583,000	-177,000	1,211,000	-1,184,000	74,000	-246,000	-369,000	-65,000	64,000	36,000	102,000	62,000	108,000	61,000	177,000	125,000		24,000	114,000	33,000		103,000	21,000	-283,000	92,000	-39,000	-7,000	339,000	-206,000	-147,000
amortization of prepaid royalties																																																												0	0	0	827,000
restricted cash																																																						2,845,000	3,000				-7,991,000																									2,981,000	-146,000	-9,000	-4,000
proceeds from sale of equipment																																																																				4,000	0	185,000
excess tax provision benefit from share-based payment arrangements
net profit																																																					-344,000	28,492,000	20,984,000	20,449,000	19,264,000	11,162,000	15,841,000	9,905,000	16,815,000	32,603,000	14,930,000	11,492,000	-49,942,000	4,545,000	2,636,000	5,157,000	4,030,000	5,304,000	9,460,000	13,618,000	6,978,000	-17,269,000	-10,320,000	-2,610,000	-4,764,000	528,000	-1,516,000	1,121,000	3,318,000	3,772,000	557,000
adjustments to reconcile net profit to net cash from operating activities:
changes in assets and liabilities, net of acquired assets and liabilities:
gain on retirement and disposal of fixed assets																																																									-15,000														-5,000
loss on retirement and disposal of fixed assets																																																							52,000					1,000	49,000	5,000	6,000	17,000	9,000	5,000	6,000	-4,000	84,000	126,000			29,000				5,000		9,000		17,000	40,000	6,000		50,000
litigation settlement costs paid in stock
benefit from doubtful accounts and returns
payments on short-term obligations
benefit from doubtful accounts																																																									-46,000	77,000	-162,000				-200,000			316,000	201,000											-1,000	45,000	275,000	100,000	80,000	86,000	-315,000
puchases of marketable securities
cash and cash equivalents, beginning of period																																																									0	0	294,664,000
cash and cash equivalents, end of period																																																									33,622,000	-140,001,000	308,608,000
purchase of property and equipment																																																										-5,697,000	-2,825,000	-6,099,000	-3,083,000	-4,319,000	-4,530,000																	-1,662,000	-2,347,000	-3,397,000	-1,655,000	-3,089,000	-985,000	-2,881,000	-630,000
acceleration of stock-based compensation
loss on impairment of fixed assets
proceeds from sale of property and equipment																																																																										-1,000	0					7,000	0
repurchases of common stock
deferred income taxes																																																													267,000	12,389,000	4,975,000
(benefit from) benefit from doubtful accounts																																																													140,000
purchases of marketable securities																																																																																					-1,998,000
cash and cash equivalents at beginning of period																																																													0	0	166,487,000		0			0	0	89,140,000	0	0	55,113,000		0	0	74,219,000		0		0	0	44,939,000		0	0	35,552,000
cash and cash equivalents at end of period																																																													29,123,000	45,394,000	190,407,000		13,779,000			15,417,000	-49,341,000	113,680,000	22,375,000	9,385,000	56,209,000		16,548,000	-14,297,000	71,783,000		4,340,000		7,116,000	8,283,000	47,816,000		5,535,000	-2,282,000	33,997,000
prepaid expenses and other current assets																																																														-2,967,000	-738,000							698,000
litigation settlement costs and amortization of prepaid royalties																																																																4,258,000
changes in assets and liabilities, net of acquisition effect:
payments on line of credit
provision from doubtful accounts
non-cash restructuring charges
repurchased shares of common stock
net cash from (used) in investing activities
stock-based compensation expense																																																																				4,390,000	4,775,000	4,011,000	3,388,000	2,865,000	2,522,000		2,277,000	2,266,000	2,205,000		9,000		1,666,000	1,782,000	2,217,000		313,000	377,000	252,000
payments on capital leases
benefit of doubtful accounts
income tax benefits from exercise of stock options
proceeds from line of credit																																																																										0
income tax benefit from exercise of stock options																																																																							-70,000
employees’ taxes withheld and paid for restricted stock
effect of foreign exchange rate on cash and cash equivalents																																																																									115,000
amortization of deferred stock-based compensation
compensation expense for accelerated vesting of stock options																																																																																				139,000	0	450,000	370,000
benefit from (benefit of) doubtful accounts
loss on retirement, disposal and impairment of fixed assets																																																																																							145,000
changes in assets and liabilities, net of acquisition effect
accrued and other long term liabilities
payments for acquisition, net of cash acquired
purchase for intangible assets
proceeds from payment on stockholders’ notes receivable																																																																																0	0	0	17,000	330,000	18,000	453,000	120,000
repurchase of common stock																																																																																				-14,000	-1,000
payments on capital lease obligations
(gain) loss on retirement and disposal of fixed assets
non-cash accretion on marketable securities																																																																																			-2,000	3,000	-9,000	-5,000	12,000
changes in assets and liabilities, net of acquisition effects:
payments of debt obligations
deferred revenue																																																																															-491,000	2,459,000	666,000	65,000	-46,000	-188,000	135,000	3,400,000	363,000
non-cash interest income on notes receivable from stockholders																																																																																				-3,000	-8,000	-15,000	-20,000
allowance for excess and obsolete inventory
changes in operating assets and liabilities:
payments for acqusition, net of cash acquired
other current assets																																																																																	-505,000	-29,000	524,000		355,000	544,000	-1,745,000
accrued liabilities																																																																															876,000		2,046,000	3,280,000	-2,964,000
decrease in restricted cash
payments on debt obligations																																																																																	-485,000	-497,000	-496,000		-546,000	-544,000	-541,000
decrease (increase) in restricted cash																																																																																	0	71,000	87,000
proceeds from draw down of line of credit
deferred costs																																																																																		-27,000	-76,000	-171,000	275,000	-12,000	108,000
non-cash interest expense on convertible subordinated notes
benefit from excess and obsolete inventory
proceeds from sale of marketable securities
payments for incurred ipo costs
amortization of deferred stock compensation																																																																																					3,066,000	3,521,000	3,641,000
other accrued liabilities																																																																																					2,261,000	3,859,000	1,087,000
benefit for doubtful accounts
realized loss on marketable securities
amortization of capitalized financing costs and debt discount
non-cash interest expense on convertible subordinated note
proceeds from issuance of convertible preferred stock, net of issuance costs
proceeds from convertible subordinated notes
repayment of line of credit

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.